Rein Therapeutics Inc. (RNTX)
NASDAQ: RNTX · Real-Time Price · USD
1.450
-0.040 (-2.68%)
At close: Apr 28, 2026, 4:00 PM EDT
1.450
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:00 PM EDT
Rein Therapeutics Market Cap
Rein Therapeutics has a market cap or net worth of $40.94 million as of April 28, 2026. Its market cap has increased by 19.35% in one year.
Market Cap
40.94M
Enterprise Value
38.56M
1-Year Change
19.35%
Ranking
Category
Stock Price
$1.45
Market Cap Chart
Since June 29, 2017, Rein Therapeutics's market cap has decreased from $158.90M to $40.94M, a decrease of -74.24%. That is a compound annual growth rate of -14.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 41.80M | 37.05% |
| Dec 31, 2025 | 30.50M | -38.76% |
| Dec 31, 2024 | 49.80M | 260.87% |
| Dec 29, 2023 | 13.80M | 27.78% |
| Dec 30, 2022 | 10.80M | -78.82% |
| Dec 31, 2021 | 51.00M | 20.57% |
| Dec 31, 2020 | 42.30M | 166.04% |
| Dec 31, 2019 | 15.90M | 28.23% |
| Dec 31, 2018 | 12.40M | -92.01% |
| Dec 29, 2017 | 155.10M | -2.39% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PDS Biotechnology | 50.26M |
| Atossa Therapeutics | 49.08M |
| Nutriband | 48.57M |
| Telomir Pharmaceuticals | 48.13M |
| Xilio Therapeutics | 48.05M |
| Hyperion DeFi | 47.50M |
| Mereo BioPharma Group | 46.29M |
| Dogwood Therapeutics | 46.09M |